(Total Views: 534)
Posted On: 07/10/2022 2:23:21 PM
Post# of 156484
i figure with all the bo talk flying about for leronlimab we could make a case
for our mTNBC and cancer being worth at least $30 a share alone. with gsk employees writing about our mTNBC makes it even more valuable. then covid and nash ,hiv ,and all the other possible indications like ALZ. how do we get compensated down the road i know there is a term for it?
drD3 hours agoReplied to a reaction
CytoDyn Inc.
@VT16 How will that $1 salary and no shares look at the negotiating table ? Because wether you like it or not , Dr Kelly is the one at the negotiating table in case you don’t know that yet . The only difference is that as of Monday he has Dr Cyrus to sit next to him and help navigate the process with his expertise in M&A . So no , not a good plan at all , not even . Juvenile perspective in fact
for our mTNBC and cancer being worth at least $30 a share alone. with gsk employees writing about our mTNBC makes it even more valuable. then covid and nash ,hiv ,and all the other possible indications like ALZ. how do we get compensated down the road i know there is a term for it?
drD3 hours agoReplied to a reaction
CytoDyn Inc.
@VT16 How will that $1 salary and no shares look at the negotiating table ? Because wether you like it or not , Dr Kelly is the one at the negotiating table in case you don’t know that yet . The only difference is that as of Monday he has Dr Cyrus to sit next to him and help navigate the process with his expertise in M&A . So no , not a good plan at all , not even . Juvenile perspective in fact
(3)
(0)
